- For Patients
- Introduction to the Marshall Protocol
- Length of the MP
- Immunopathology
- Managing immunopathology
- Food and drink
- Light restriction
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Starting the Marshall Protocol
- Resources for patients
- Marshall Protocol summary
- Palliative vs. curative treatments
- Patient interviews on Bacteriality
- Non-MP treatments
- Glossary
- The Protocol
- Marshall Protocol summary
- Publications and presentations
- Science behind immunopathology
- Science behind olmesartan (Benicar)
- Safety of olmesartan
- Resources for physicians
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Physicians' concerns about the MP
- Notice for emergency medical personnel
- The Pathogenesis
- Publications and presentations
- Science behind Marshall Pathogenesis
- Microbes in the human body
- Successive infection and variability in disease
- Autoimmune theory of disease
- Science behind vitamin D
- Metabolism of vitamin D and the VDR
- Th1 Spectrum Disorder - how chronic inflammatory diseases are related
- Transmission of bacteria and onset of chronic disease
- Evolutionary perspective on disease
- Incidence and prevalence of disease
- Evidence that chronic disease is caused by pathogens
- Diseases
- Foundation
- Related Sites
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revision | Next revisionBoth sides next revision | ||
| home:symptoms:skin [01.03.2012] – external edit 127.0.0.1 | home:symptoms:skin [08.28.2012] – paulalbert | ||
|---|---|---|---|
| Line 67: | Line 67: | ||
| Patients experiences | Patients experiences | ||
| + | |||
| + | |||
| + | |||
| + | |||
| + | ===== Atopic dermatitis ===== | ||
| + | |||
| + | < | ||
| + | 4. | ||
| + | Differential mRNA expression of antimicrobial peptides and proteins in atopic dermatitis as compared to psoriasis vulgaris and healthy skin. | ||
| + | Gambichler T, Skrygan M, Tomi NS, Othlinghaus N, Brockmeyer NH, Altmeyer P, Kreuter A. | ||
| + | Int Arch Allergy Immunol. 2008; | ||
| + | PMID: 18446049 [PubMed - indexed for MEDLINE] | ||
| + | Related citations Remove from clipboard | ||
| + | |||
| + | |||
| + | The role of antimicrobial peptides in human skin and in skin infectious diseases. | ||
| + | Schittek B, Paulmann M, Senyürek I, Steffen H. | ||
| + | Infect Disord Drug Targets. 2008 Sep; | ||
| + | PMID: 18782030 [PubMed - indexed for MEDLINE] | ||
| + | |||
| + | |||
| + | </ | ||
| + | |||
| + | |||
home/symptoms/skin.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.